Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Sensation Disorders D012678 2 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Ileus D045823 3 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Cardiomyopathies D009202 10 associated lipids
Retinal Detachment D012163 10 associated lipids
Influenza, Human D007251 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lung Injury D055370 14 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Tuberculosis D014376 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Sarcoma 180 D012510 21 associated lipids
Anemia D000740 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Fibrosis D005355 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Glioblastoma D005909 27 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Kawamori T et al. Role for sphingosine kinase 1 in colon carcinogenesis. 2009 FASEB J. pmid:18824518
Peyruchaud O Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer. 2009 Anticancer Agents Med Chem pmid:19442039
Kenagy RD et al. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. 2009 J. Vasc. Surg. pmid:19307078
Salinas NR et al. Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720. 2009 Pathol. Oncol. Res. pmid:19214784
Choi SK et al. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery. 2009 Cardiovasc. Res. pmid:19218288
Tokumura A et al. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. 2009 Int J Med Sci pmid:19521548
Huang YL et al. Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P1) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells. 2009 J. Biochem. pmid:19692429
Antoon JW et al. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. 2009 J. Med. Chem. pmid:19694470
Hashimoto T et al. Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesis. 2009 J. Lipid Res. pmid:19020339
Maeurer C et al. Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM. 2009 Cell. Signal. pmid:19000755
Ikeda H et al. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. 2009 J. Lipid Res. pmid:18955732
Ranty ML et al. Ceramide production associated with retinal apoptosis after retinal detachment. 2009 Graefes Arch. Clin. Exp. Ophthalmol. pmid:18958490
Young N et al. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. 2009 Mol. Cancer Res. pmid:19147534
Weis N et al. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. 2009 Mol. Biol. Cell pmid:19129475
Chang CL et al. S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. 2009 Am. J. Physiol., Cell Physiol. pmid:19474291
Schulz C et al. Trafficking of murine hematopoietic stem and progenitor cells in health and vascular disease. 2009 Microcirculation pmid:19479622
Kimber I et al. Langerhans cell migration: not necessarily always at the center of the skin sensitization universe. 2009 J. Invest. Dermatol. pmid:19603050
Pyne NJ et al. New aspects of sphingosine 1-phosphate signaling in mammalian cells. 2009 Adv. Enzyme Regul. pmid:19534035
Price MM et al. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. 2009 FASEB J. pmid:19535686
Hu W et al. Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity. 2009 J. Lipid Res. pmid:19369694
Miranda GE et al. Sphingosine-1-phosphate is a key regulator of proliferation and differentiation in retina photoreceptors. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19357361
Tao R et al. Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization. 2009 J. Cardiovasc. Pharmacol. pmid:19433984
Yang G et al. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19435851
Yin H et al. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. 2009 J. Biol. Chem. pmid:19286662
Hofmann U et al. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. 2009 Cardiovasc. Res. pmid:19416991
Ader I et al. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. 2009 Cancer Res. pmid:19383898
Okajima F et al. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. 2009 Endocr. J. pmid:18753704
Brinkmann V FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. 2009 Br. J. Pharmacol. pmid:19814729
Wojciak JM et al. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19815502
Jacobson JR Pharmacologic therapies on the horizon for acute lung injury/acute respiratory distress syndrome. 2009 J. Investig. Med. pmid:19820408
Jenne CN et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. 2009 J. Exp. Med. pmid:19808259
Long DA and Price KL Sphingosine kinase-1: a potential mediator of renal fibrosis. 2009 Kidney Int. pmid:19789541
Heo K et al. Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. 2009 BMB Rep pmid:19874715
Jongsma M et al. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). 2009 Br. J. Pharmacol. pmid:19309361
Bedia C et al. Synthesis of a fluorogenic analogue of sphingosine-1-phosphate and its use to determine sphingosine-1-phosphate lyase activity. 2009 Chembiochem pmid:19226506
Rodgers A et al. Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells. 2009 Stem Cells Dev. pmid:19228106
Gellings Lowe N et al. Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts. 2009 Cardiovasc. Res. pmid:19228708
Garcia JG Concepts in microvascular endothelial barrier regulation in health and disease. 2009 Microvasc. Res. pmid:19232241
Igarashi J and Michel T Sphingosine-1-phosphate and modulation of vascular tone. 2009 Cardiovasc. Res. pmid:19233865
Sattler K and Levkau B Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. 2009 Cardiovasc. Res. pmid:19233866
Scherer M et al. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. 2009 Clin. Chem. pmid:19325012
Maceyka M et al. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling. 2009 J. Lipid Res. pmid:18987387
Sali M et al. Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection. 2009 Jan-Mar Int J Immunopathol Pharmacol pmid:19309565
Syuto T et al. Mammalian Diaphanous (mDia) may be involved in the signal transduction of sphingosine-1-phosphate on developing actin stress fiber of human fibroblasts. 2009 Jul-Aug Wound Repair Regen pmid:19614924
Maiese K Choices and outcomes: Extending basic biology to clinical care. 2009 Jul-Aug Oxid Med Cell Longev pmid:20592765
Vessey DA et al. Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning. 2009 Jul-Aug Oxid Med Cell Longev pmid:20592769
Voelkel NF and Spiegel S Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthma. 2009 Nov-Dec Immunol. Cell Biol. pmid:19546879
Hannoun A et al. Addition of sphingosine-1-phosphate to human oocyte culture medium decreases embryo fragmentation. 2010 Reprod. Biomed. Online pmid:20093086
Murakami A et al. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. 2010 Mol. Pharmacol. pmid:20097776
Bektas M et al. Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. 2010 J. Biol. Chem. pmid:20097939
Riccio A New endogenous regulators of class I histone deacetylases. 2010 Sci Signal pmid:20051592
Brown M et al. Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium. 2010 Microvasc. Res. pmid:20053363
Fletcher JI et al. ABC transporters in cancer: more than just drug efflux pumps. 2010 Nat. Rev. Cancer pmid:20075923
Egom EE et al. Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling. 2010 Prog. Biophys. Mol. Biol. pmid:20080123
Claas RF et al. Enhanced Ca2+ storage in sphingosine-1-phosphate lyase-deficient fibroblasts. 2010 Cell. Signal. pmid:19913094
Park SW et al. Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. 2010 Shock pmid:19752779
Brakch N et al. Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. 2010 Eur. Heart J. pmid:19773225
Medlin MD et al. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:20702813
Nishimura B et al. The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea. 2010 Neurosci. Lett. pmid:20709153
Swan DJ et al. Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation. 2010 J. Cell. Mol. Med. pmid:20716131
Nelson CJ et al. Global analysis of circulating metabolites in hibernating ground squirrels. 2010 Comp. Biochem. Physiol. Part D Genomics Proteomics pmid:20728417
Yonesu K et al. A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate. 2010 Biol. Pharm. Bull. pmid:20823564
Morishige J et al. A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag. 2010 Rapid Commun. Mass Spectrom. pmid:20213695
Chen JH et al. Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival. 2010 J. Lipid Res. pmid:19965613
Gorbunova E et al. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. 2010 J. Virol. pmid:20463083
Shea BS et al. Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. 2010 Am. J. Respir. Cell Mol. Biol. pmid:20081052
Okae H and Iwakura Y Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. 2010 Dev. Dyn. pmid:20186915
Nam JH et al. Ca2+ signaling induced by sphingosine 1-phosphate and lysophosphatidic acid in mouse B cells. 2010 Mol. Cells pmid:20069383
Vessey DA et al. Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning. 2010 J. Cardiovasc. Pharmacol. Ther. pmid:20200324
Lee H et al. Bone marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting sphingolipid metabolism and increasing sphingosine-1-phosphate. 2010 Stem Cells pmid:20201063
Qi X et al. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice. 2010 Eur. J. Pharmacol. pmid:20206620
Xu R et al. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes. 2010 FASEB J. pmid:20207939
Hu WM et al. Effect of S1P5 on proliferation and migration of human esophageal cancer cells. 2010 World J. Gastroenterol. pmid:20397263
Ratajczak MZ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. 2010 Leukemia pmid:20357827
Chiba Y et al. SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. 2010 J. Pharmacol. Sci. pmid:20948165
Alford SK et al. Prediction of sphingosine 1-phosphate-stimulated endothelial cell migration rates using biochemical measurements. 2010 Ann Biomed Eng pmid:20358290
Kanno T et al. Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. 2010 Neuroscience pmid:20950672
Browne CD et al. SHEP1 partners with CasL to promote marginal zone B-cell maturation. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20956287
Zhang N et al. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. 2010 Autophagy pmid:20935520
Liu G et al. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. 2010 Nat. Immunol. pmid:20852647
Scherer EQ et al. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. 2010 Stroke pmid:20930159
Greco E et al. Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells. 2010 Immunology pmid:19878354
Norman E et al. Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms. 2010 J. Neurochem. pmid:20456020
Cao C et al. The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. 2010 J. Clin. Invest. pmid:20458145
Park SW et al. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. 2010 Lab. Invest. pmid:20458275
Itoh R et al. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells. 2010 J. Bone Miner. Metab. pmid:20458606
Yoshida T et al. Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:20431071
Shayman JA The riddle of the sphinx redux. 2010 Kidney Int. pmid:20431574
Hirahara K et al. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. 2010 Cytokine Growth Factor Rev. pmid:21084214
Kułakowska A et al. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. 2010 Neurosci. Lett. pmid:20434523
Szczepaniak WS et al. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20435688
Rosa JM et al. Permissive role of sphingosine on calcium-dependent endocytosis in chromaffin cells. 2010 Pflugers Arch. pmid:20640579
Cuvillier O et al. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. 2010 Curr Mol Pharmacol pmid:20302564
Long JS et al. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells. 2010 Mol. Cell. Biol. pmid:20516217
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Seo YJ et al. Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. 2010 J. Virol. pmid:20519401
Lee MH et al. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. 2010 J. Lipid Res. pmid:20522601
Blom T et al. An autocrine sphingosine-1-phosphate signaling loop enhances NF-kappaB-activation and survival. 2010 BMC Cell Biol. pmid:20573281
Alvarez SE et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. 2010 Nature pmid:20577214
Kamradt T and Frey O Arthritis: where are the T cells? 2010 Arthritis Res. Ther. pmid:20537200